Personalized Medicine Through Advanced Genomics

Oct 17, 2017 by in NEUROLOGY Comments Off on Personalized Medicine Through Advanced Genomics

Fig. 3.1 Cost of sequencing a single human genome. Sequencing costs have fallen rapidly over the past five years as next-generation technologies become increasingly efficient. Graph is reproduced using data from…

read more

Immunotherapy for High-Grade Gliomas

Oct 17, 2017 by in NEUROLOGY Comments Off on Immunotherapy for High-Grade Gliomas

NIH clinical trial Type Phase Eligibility criteria Primary outcome Dosing regimen Treatment groups NCT02311920 Checkpt 1 Newly diagnosed GBM Maximum safe dose In addition to TMZ, Arm I receives anti-CTLA4…

read more

Glioblastoma

Oct 17, 2017 by in NEUROLOGY Comments Off on Glioblastoma

Fig. 18.1 Survival rates of glioblastoma patients by age groups [1] Endogenous Risk Factors The cell of origin of glioblastoma is thought to be a neural stem cell (Box 18.1), but risk…

read more

Targeted Therapy of IDH1-Mutated Tumors

Oct 17, 2017 by in NEUROLOGY Comments Off on Targeted Therapy of IDH1-Mutated Tumors

Fig. 10.1 Molecular mechanisms of IDH-associated tumorigenesis. Wild-type IDH1/2 (wtIDH1/2) converts isocitrate (generated through the citric acid (TCA) cycle) into α-KG, producing NADPH in the process. Mutant IDH1/2 (mutIDH1/2) converts isocitrate…

read more

Tumor-Specific Approach: Oligodendroglioma (IDH1 Mutated, 1p/19q Deleted)

Oct 17, 2017 by in NEUROLOGY Comments Off on Tumor-Specific Approach: Oligodendroglioma (IDH1 Mutated, 1p/19q Deleted)

© Springer International Publishing AG 2017Jennifer Moliterno Gunel, Joseph M Piepmeier and Joachim M. Baehring (eds.)Malignant Brain Tumors 10.1007/978-3-319-49864-5_17 17. Tumor-Specific Approach: Oligodendroglioma (IDH1 Mutated, 1p/19q Deleted) Charles Marc Leyrer1  , Erin Murphy1   and Manmeet Ahluwalia2   (1) 9500 Euclid Ave./T-28, Cleveland,…

read more

Infiltrative Glioma

Oct 17, 2017 by in NEUROLOGY Comments Off on Infiltrative Glioma

Fig. 16.1 Schematic overview of a possible clinical decision algorithm outside clinical trials for infiltrative glioma. IDH isocitrate dehydrogenase; ATRX alpha thalassemia mental retardation X-linked; MGMT O6 methylguanine methyltransferase; G–CIMP glioma-CpG…

read more

Glioma Radiosensitizers: Exciting New Developments and Directions

Oct 17, 2017 by in NEUROLOGY Comments Off on Glioma Radiosensitizers: Exciting New Developments and Directions

© Springer International Publishing AG 2017Jennifer Moliterno Gunel, Joseph M Piepmeier and Joachim M. Baehring (eds.)Malignant Brain Tumors 10.1007/978-3-319-49864-5_15 15. Glioma Radiosensitizers: Exciting New Developments and Directions Christopher D. Corso1   and Ranjit S. Bindra1   (1) Department of Therapeutic Radiology, Yale…

read more

Mapping the Brain for Primary Brain Tumor Surgery

Oct 17, 2017 by in NEUROLOGY Comments Off on Mapping the Brain for Primary Brain Tumor Surgery

Fig. 5.1 Illustrative case of a 50 years-old frustrated left-handed patient diagnosed with a left frontal glioblastoma revealed by headaches and language disturbances. a Preoperative T1-gadolinium enhanced MRI, showing a large enhancing…

read more
Get Clinical Tree app for offline access